Adolescent immunizations: A position paper of the society for adolescent medicine

被引：67

作者：

Middleman, AB ^{[1
]}

Rosenthal, SL

Rickert, VI

Neinstein, L

Fishbein, DB

D'Angelo, L

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Univ Texas, Med Branch, Galveston, TX 77555 USA

[3] Columbia Univ, New York, NY 10027 USA

[4] Univ So Calif, Keck Sch Med, Los Angeles, CA USA

[5] Ctr Dis Control & Prevent, Atlanta, GA USA

[6] Childrens Natl Med Ctr, Washington, DC 20010 USA

来源：

JOURNAL OF ADOLESCENT HEALTH | 2006年 / 38卷 / 03期

关键词：

D O I：

10.1016/j.jadohealth.2006.01.002

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

New vaccines are being targeted to help protect the adolescent population from disease. The Society for Adolescent Medicine strongly urges compliance with adolescent vaccination recommendations provided by the Advisory Committee on Immunization Practices. These vaccines will significantly impact the health and well-being of the adolescent population. To enhance vaccination compliance and access to prevention health care and promotion, the Society supports linking vaccination to the three distinct comprehensive preventive health care visits already recommended by multiple organizations during early, middle, and late adolescence. In addition, multiple provider strategies should be used to increase vaccination rates among adolescents. (c) 2006 Society for Adolescent Medicine. All rights reserved.

引用

收藏

页码：321 / 326

页数：6

相关论文

共 33 条

[11] Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine [J].

Goldie, SJ ;

Kohli, M ;

Grima, D ;

Weinstein, MC ;

Wright, TC ;

Bosch, FX ;

Franco, E .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (08) :604-615

[12] Hepatitis B vaccine administered to children and adolescents at yearly intervals [J].

Halsey, NA ;

Moulton, LH ;

O'Donovan, JC ;

Walcher, JR ;

Thoms, ML ;

Margolis, HS ;

Krause, DS .

PEDIATRICS, 1999, 103 (06) :1243-1247

[13] Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial [J].

Harper, DM ;

Franco, EL ;

Wheeler, C ;

Ferris, DG ;

Jenkins, D ;

Schuind, A ;

Zahaf, T ;

Innis, B ;

Naud, P ;

De Carvalho, NS ;

Roteli-Martins, CM ;

Teixeira, J ;

Blatter, MM ;

Korn, AP ;

Quint, W ;

Dubin, G .

LANCET, 2004, 364 (9447) :1757-1765

[14] Invasive meningococcal disease in adolescents and young adults [J].

Harrison, LH ;

Pass, MA ;

Mendelsohn, AB ;

Egri, M ;

Rosenstein, NE ;

Bustamante, A ;

Razeq, J ;

Roche, JC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (06) :694-699

[15] Economic considerations for pertussis booster vaccination in adolescents [J].

Hay, JW ;

Ward, JI .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (06) :S127-S133

[16] Challenges to vaccinating adolescents - Vaccine implementation issues [J].

Humiston, SG ;

Rosenthal, SL .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (06) :S134-S140

[17] Effect of middle school entry requirements on hepatitis B vaccination coverage [J].

Jacobs, RJ ;

Meyerhoff, AS .

JOURNAL OF ADOLESCENT HEALTH, 2004, 34 (05) :420-423

[18] Access to medical care for adolescents: Results from the 1997 Commonwealth Fund Survey of the Health of Adolescent Girls [J].

Klein, JD ;

Wilson, KM ;

McNulty, M ;

Kapphahn, C ;

Collins, KS .

JOURNAL OF ADOLESCENT HEALTH, 1999, 25 (02) :120-130

[19] Pertussis in adolescents and adults: Should we vaccinate? [J].

Lee, GM ;

LeBaron, C ;

Murphy, TV ;

Lett, S ;

Schauer, S ;

Lieu, TA .

PEDIATRICS, 2005, 115 (06) :1675-1684

[20]

MARKOWITZ L, 2005, HUMAN PAPILLOMAVIRUS

← 1 2 3 4 →